AstraZeneca - Controversies in Breast Cancer (ID 48)

Treatment beyond CDK4/6i - what comes next? (ID 471)

Lecture Time
12:00 - 12:15
Speakers
  • Rebecca A. Dent (Singapore, Singapore)
Authors
  • Rebecca A. Dent (Singapore, Singapore)
Session Name
AstraZeneca - Controversies in Breast Cancer (ID 48)
Room
Cologne Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30